Related Experiment Video
Updated: May 9, 2026
05:17
Swimming Exercise Protocol and Care Methods for Pregnant Rats
Published on: April 5, 2024
Pregnancy and heart disease: time for a randomized controlled trial
Mark Johnson1, Michael Gatzoulis, Jolien Roos-Hesselink
1Academic Department of Obstetrics and Gynaecology, Faculty of Medicine, Imperial College London, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
International Journal of Cardiology
|July 30, 2013
Summary
Maternal cardiac disease deaths are rising despite efforts. More randomized controlled trials are urgently needed to improve outcomes for pregnant women with heart conditions.
Area of Science:
- Cardiology
- Obstetrics
- Maternal Health
Background:
- Cardiac disease is the leading cause of maternal mortality globally.
- Existing literature is predominantly case series, limiting evidence-based practice.
- Despite collaborative efforts, maternal deaths from heart conditions are increasing.
Discussion:
- The critical need for high-quality evidence through randomized controlled trials (RCTs) in managing cardiac disease during pregnancy is highlighted.
- Addressing key research questions in this field is essential to reverse mortality trends.
- The challenges in conducting RCTs in this population are acknowledged but deemed necessary.
Key Insights:
- Cardiac disease remains the primary driver of maternal mortality.
- Current research is insufficient to guide clinical practice effectively.
- A shift towards rigorous research methodologies is imperative.
Outlook:
- Future research should prioritize multicenter randomized controlled trials to establish best practices.
- Improved understanding and management of peripartum cardiomyopathy and other cardiac conditions are crucial.
- Collaborative efforts between cardiology and obstetrics are vital for reducing preventable maternal deaths.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...